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Twelve novel oxo-technetium and oxo-rhenium complexes based on N2S2-, N2SO- or N3S-tetradentate semi-rigid
ligands have been synthesised and studied herein. By reacting the ligands with a slight excess of suitable [MO]3+
precursor (ReOCl3(PPh3)2 or [NBu4][99gTcOCl4]), the monoanionic complexes of general formula [MO(Ph–XN2S)]−
could be easily produced in high yield. The complexes have been characterized by means of IR, electrospray mass
spectrometry, elemental analysis, NMR and conductimetry. The crystal structures of [PPh4][ReO(Ph–ON2S)] 1b and
[NBu4][99gTcO(Ph–ON2S)] 1c have been established. The [MO]3+ moiety was coordinated via the two deprotonated
amide nitrogens, the oxygen and the terminal sulfur atoms in 1b and 1c. In both compounds, the ON2S coordination
set is in the equatorial plane, and the complexes adopted a distorted square-pyramidal geometry with an axial
oxo-group. The chemical and structural identity of the different prototypic complexes (rhenium, 99gTc complexes and
their corresponding 99mTc radiocomplexes) have been also established by a comparative HPLC study.
Introduction
Technetium and rhenium are known for their useful applications
in nuclear medicine. 99mTc (140 keV c emitter, t1/2 6.02 h,
convenient availability from the 99Mo/99mTc generator) is widely
used for diagnostic imaging, while 186Re (1.07 MeV b− emitter,
t1/2 90 h) and 188Re (2.12 MeV b− emitter, t1/2 17 h) are two of the
most attractive isotopes for applications in targeted radionuclide
therapy.1,2 The effortsmade in this field in recent years have led to
the synthesis of novel, selective and effective chelates.2,3 Among
them, N2S2, N2O2 or N3S frameworks are the most common
chelate systems used to bind the [TcO]3+ and [ReO]3+ cores.4
In connection with our interest in the preparation of new
substitution-inert technetium and rhenium compounds, we have
recently reported the synthesis of a new family of semi-rigid
N2S2, N2OS or N3S tetradentate ligands, which are charac-
terised by the presence of an aromatic cycle in the framework
(Scheme 1). This design (i) enhances the sp2 character of the
nitrogen atom bonded to the metal, (ii) promotes rigidity to the
square-pyramidal basewhich can favour and stabilise the chelate
ring by an entropic effect,5 and (iii) avoids the formation of
isomers. Thus, coordination of selected tetraanionic tetradentate
ligands (Scheme 1) towards usual rhenium (ReOCl3(PPh3)2
or [NBu4][ReO4]) and technetium ([NBu4][99gTcOCl4]) precur-
sors gave straightforwardly complexes of the general formula
[C][MO(Ph–XN2S)] (C is Na, NBu4, Et3NH, PPh4; X = O, S,
NH, NMe) under mild conditions. Complexes [PPh4][ReO(Ph–
Scheme 1 Ph–XN2S Ligands.
ON2S)] 1b and [NBu4][99gTcO(Ph–ON2S)] 1c were characterised
by single-crystal X-ray analyses, the latter constituting the first
example of 99gTc crystal structure with this kind of semi-rigid
ligands.
The reactivity of these ligands with 99mTc and the stability of
the corresponding radiocomplexes, were also investigated.While
trianionic tetradentate ligands gave quite stable [99mTcO]3+ com-
plexes with two syn/anti epimers,6 these tetraanionic tetraden-
tate ligands produced unique and highly stable [99mTcO]3+
species,7 in accordance to a recent contribution of Papachristou
et al.8 Moreover, our new tetraanionic chelating ligands can
be functionalized through the aromatic ring (by amine or acid
function) to obtain bifunctional chelating agents (BCAs) for
targeting purposes.
The structural identity of the corresponding Re, 99gTc and
99mTc compounds was assessed by means of HPLC studies.
Results and discussion
The ligands
Four tetradentate semi-rigid ligands (Ph–ON2S(Trt), Ph–
S(Trt)N2S(Trt), Ph–N3S(Trt), Ph–N(Me)N2S(Trt), general ab-
breviation, Ph–XN2S; Trt = trityl) have been used as chelating
agents in the present work. They were synthesised in good
yield via multistep reactions as previously described.7 Ph–XN2S
ligands act as tetraanionic ligands X−N−N−S−, by coordination
via the charged X aromatic function, the two amide nitrogens
and the sulfur atoms. Very preliminary studies on radiolabelling
of these ligands showed that they form stable 99mTc complexes
1d–4d at tracer level.7
Preparation of rhenium(V) complexes
Ligand-exchange reactions of labile ReOCl3(PPh3)29 with a
slight excess of the relevant tetradentate ligand (1 : 1.3 metal :
ligand ratio) in the presence of a deprotonating agent (Scheme 2)
Scheme 2 Preparation of the rhenium complexes.
gave [MO(Ph–XN2S)]− compounds in high yield. In more
detail, reactions of Ph–ON2S(Trt) or Ph–S(Trt)N2S(Trt) with
ReOCl3(PPh3)2 in the presence of sodium acetate in methanol
or toluene resulted in oxorhenium complexes 1a or 2a as the
sodium salts in 97 and 83% yield, respectively. The cleavage
of trityl group was accomplished during the coordination of
the ligand to the ReO3+ core and this is in agreement with the
acidic contribution of the metal in the mechanism of sulfur
detritylation.10
By using the above detailed conditions with Ph–N3S(Trt)
or Ph–N(Me)N2S(Trt), only a mixture of several rhenium
complexes were obtained. However, use of triethylamine instead
of sodium acetate as deprotonating agent determined a quite
rapid change of the methanol solution colour from greenish-
yellow to the final reddish-brown. The coordination took
place in 4 h at reflux and led, for each ligand, to a unique
oxorhenium complex (3a, 4a) as the triethylammonium salt, in
good yield (>85%). The presence of triethylammonium chloride
as a persistent contaminant, even after column chromatog-
raphy purification, suggested the replacement of the counter-
cation with larger PPh4+. Metathesis reactions were performed
in dichloromethane/methanol solutions at room temperature.
Under these conditions, analytically pure complexes 1b–4b were
obtained in high yield. Complex 1b gave red crystals suitable
for X-ray analysis from dichloromethane–methanol solution.
This compound, as well as all other complexes prepared in this
study, contains a metal-monooxo core with no additional group
coordinated trans to the yl-oxygen. This behaviour is typical of
anionic five-coordinated complexes in which the ligand contains
good p donor atoms.11,12
Rhenium complexation of the trityl protected Ph–ON2S(Trt)
ligand was also performed in refluxing methanol by direct
reduction of tetrabutylammonium perrhenate in the presence
of an excess of tin chloride,13 giving [NBu4][Ph–ON2S], 1e.
These oxo-rhenium compounds are soluble in dichloro-
methane, chloroform,methanol and insoluble in water. They are
indefinitely stable in the solid state as well as in organic solvents
(for a period of months) as shown by HPLC and NMR. The
stability is not affected by the presence of air or moisture.
All the oxo-rhenium complexes were unambiguously identi-
fied by conventional analytical and spectroscopic techniques. In
particular, IR spectra showed an intense band in the range 948–
969 cm−1 attributable to the Re=O stretching vibration,14 and
two strongbands in the range 1618–1667 cm−1 assigned to mC=O of
both amides (Table 1).Nomultiple strong bandswere detected in
the ranges 1500–1560 and 3200–3400 cm−1 of complexes 1a, 1b,
1e, 2a and 2b, confirming that the amides were deprotonated.15
Conversely, complexes 3a, 4a and 3b exhibited vibrations in
the 3200–3400 cm−1 range, due to the presence of the triethy-
lammonium counter-cation and/or of the aromatic amine N–H
stretching vibrations, respectively. The IR spectra of complexes
1b–4b exhibited five additional bands of the PPh4+ moiety.
Table 1 Selected 1H, 13C NMR and IR data of oxorhenium and oxotechnetium complexes 1–4
NMR IR
CH2S CH2N C=O C=O M=O
dH(Hexo/Hendo) (ppm); JH–H/Hz dC (ppm) m/cm−1
1a 3.81/4.15; J = 17.2 4.54/5.46; J = 18.3 187.3/194.5 1661/1624 968
2s 3.71/3.90; J = 17.4 4.54/4.94; J = 18.9 190.5/194.8 1662/1620 964
3a 3.81/4.02; J = 17.2 4.55/5.12; J = 18.7 188.1/194.0 1635/1613 956
4a 3.83/3.99; J = 17.1 4.49/5.04; J = 18.6 187.6/193.4 1647/1622 953
1e 3.79/4.13; J = 17.1 4.57/5.53; J = 18.4 186.9/193.1 1664/1641 968
1b 3.71/4.01; J = 16.8 4.44/5.37; J = 18.3 187.5/193.9 1667/1638 969
2b 3.72/3.87; J = 17.1 4.56/4.88; J = 18.9 188.7/192.2 1665/1625 962
3b 3.77/3.93; J = 16.8 4.43/5.04; J = 18.3 187.7/192.8 1648/1618 948
4b 3.79/3.97; J = 17.1 4.39/5.01; J = 18.6 187.8/193.2 1649/1625 954
1c 3.85/4.04; J = 16.9 4.61/5.19; J = 18.3 182.5/185.9 1654/1634 953
2c 3.85/4.10; J = 16.9 4.72/4.82; J = 18.9 184.0/186.4 1655/1638 945
3c 3.72/4.07; J = 16.7 4.58/4.93; J = 18.6 183.3/186.2 a a
a Not realised.
ProtonNMRofRe-complexes revealed the loss of both amide
and XR (XR = OH, NH2 or NHMe) hydrogens indicating
deprotonation and coordination. In complexes 3a,b and 4a,b
the loss of aromatic amine nitrogen hydrogens, which is unusual
in amines, may be attributed to the greater acidity imparted
to the aniline-like amine hydrogens by conjugation with the
aromatic ring.16 Moreover, only a unique signal for hydrogen
(3a,b) and the methyl group (4a,b) of the aromatic nitrogen,
respectively, was detected indicating sp2 hybridization for the
aromatic amine nitrogen. Methylene protons of the tetradentate
ligand framework were found to be diastereotopic (AB pattern)
with coupling constants in the range 17–19 Hz. Exo and endo
a protons of the glycine residue were detected at 4.54 (H2a)
and 5.46 ppm (H2b) for 1a, downfield shifted compared to the
corresponding protons in the uncoordinated ligand (3.76 ppm).
Similarly, the a protons close to the thiolate group were
deshielded from 3.21 ppm in the uncoordinated ligand to 3.81
(H1a) and 4.15 ppm (H1b) for 1a (Fig. 1).
Fig. 1 Proton NMR spectra for complex 1a (MeOD, 25 ◦C).
Similar magnetic inequivalence of CH2 protons attached to
amide donor atoms was observed in MAG3Re type complexes.17
According to the literature,10 we assigned the downfield signal
of both AB patterns to the endo protons (syn to the Re=O
group) and the upfield signals to the exo ones (anti to the Re=O
group).18 13C NMR spectra confirmed coordination of the lig-
ands showing remarkable downfield shifts of the carbon signals
nearby the ligating atom set compared to those of the corre-
sponding carbons in the free ligand. For example, the amide car-
bons were downfield shifted by 20–25 ppm upon coordination,19
and, analogously, the glycine a carbons moved from 42–45 ppm
in the free ligands to 60–62 ppm in the complexes.
Negative-ion ESI-MS spectra of each Re-complex showed
the parent peak with the correct isotope distribution pattern
consistent with the monomeric anion, without significant frag-
mentation. Conductivity measurements gave values in methanol
consistent with a 1 : 1 electrolyte type.
Synthesis of 99gTc complexes
99gTc complexes 1–3c were synthesised by ligand-exchange reac-
tions starting from [NBu4][99gTcOCl4]20 and the relevant ligand
inmethanol at room temperature. Addition of triethylamine was
necessary to isolate pure 3c. In contrast, complex 4c was always
collected as a mixture of two species (Scheme 3).
The IR features of 1c–3c were similar to those observed in
oxorheniumanalogues.TheTc=Ostretching vibration appeared
consistently at 950 cm−1, ca. 15–20 cm−1 ipsochromic shifted
compared to the vibrations observed in the corresponding
oxorhenium compounds. This difference is common in series
of isostructural mono-oxo Tc and Re species.21,22
Analogously, 1H and 13C NMR values do not change signifi-
cantly on going from oxorhenium to oxotechnetium complexes,
indicating structural similarity (Table 1) that was confirmed by
the X-ray analysis of complex 1c.
X-Ray crystallography
The [PPh4][ReO(Ph–ON2S)] 1b and [NBu4][99gTcO(Ph–ON2S)]
1c complexes were crystallised by slow evaporation of a
dichloromethane–ethanol and a dichloromethane–isopropanol
solution, respectively. Crystallographic data and structure
Scheme 3 Synthesis of 99gTc complexes 1c, 2c, 3c.
refinement as well as selected bond distances and angles
involving the atoms of the anions are summarised in Tables 2
and 3, respectively. Perspectives drawings of the two complexes
are shown in Figs. 2 and 3.
Both compounds are monoanionic, the [MO]3+ core charge
being balanced by the four hydrolisable functions of the
tetradentate ligand. Each asymmetric unit cell contains only
one metal complex, and the absolute configuration around the
metal is clockwise. The stereochemical notation to describe
this situation is (SP–5–24–C)–1b and (SP–5–24–C)–1c.23 The
acronym means that the complex assumes a square-pyramidal
geometry with coordination number 5, 24 is the configuration
number according to the CIP (Cahn–Ingold–Prelog) rules,24 and
the symbol C is assigned to that configuration in which the CIP
priority numbers of the ligating atoms in the equatorial plane
increase proceeding in a clockwise manner when viewing the
plane from the ligating atom on the C4 axis.
Thus, [MO(Ph–ON2S)]− complexes exhibit a distorted square-
pyramidal geometry with yl-oxygen in the apical position.
The square planes defined by the combination of nitrogen,
oxygen and sulfur atoms are little distorted, with the two amide
nitrogens and the phenolate oxygen in the plane and the sulfur
atom lying below the plane by about 0.28 and 0.30 A˚ in 1b and
1c, respectively. Re and Tc lie above the mean plane by 0.67 and
Table 2 Crystal data and structure refinement for 1b and 1c complexes
Complex [PPh4][ReO(Ph–ON2S)] 1b [NBu4][99gTcO(Ph–ON2S)] 1c
Formula C34H28N2O4PReS C26H44N3O4STc
M 777.85 592.70
Crystal system Orthorhombic Monoclinic
Color Dark red Brown
Crystal size/mm 0.21 × 0.14 × 0.64 0.20 × 0.12 × 0.06
Space group P212121 P21/n
a/A˚ 9.600(4) 9.114(2)
b/A˚ 14.588(3) 18.383(4)
c/A˚ 21.525(9) 17.360(4)
b/◦ 90 91.32(3)
V/A˚3 3015(2) 2907.8(9)
Z 4 4
T/K 298 293
Dc/g cm−3 1.714 1.354
F(000) 1536 1248
Total reflections 35340 7250
Independent reflections 9963 7250
Observed reflections [I > 2r(I)] 6195 3700
Data/restraints/parameters 6195/0/378 3700/0/315
Final R indices [I > 2r(I)] R1 = 0.0505, wR2 = 0.0962 R1 = 0.0454, wR2 = 0.1064
R Indices (all data) R1 = 0.1070, wR2 = 0.1080 R1 = 0.0900, wR2 = 0.1286
GOF 0.947 0.881
Table 3 Selected bond lengths (A˚) and angles (◦) in complexes 1b and 1c
[PPh4][ReO(Ph–ON2S)] 1b [NBu4][99gTcO(Ph–ON2S)] 1c
M(1)–O(4) 1.675(4) 1.653(2)
M(1)–O(3) 2.000(4) 1.986(2)
M(1)–N(2) 1.999(5) 1.984(3)
M(1)–N(1) 1.983(6) 1.960(3)
M(1)–S(1) 2.276(2) 2.276(1)
C(1)–S(1) 1.788(9) 1.822(4)
C(2)–O(1) 1.208(9) 1.219(4)
C(2)–N(1) 1.356(9) 1.365(5)
C(4)–O(2) 1.225(9) 1.216(5)
C(4)–N(2) 1.388(9) 1.375(5)
C(5)–N(2) 1.398(8) 1.414(5)
C(10)–O(3) 1.347(8) 1.359(4)
O(4)–M(1)–N(1) 110.9(3) 109.7(1)
O(4)–M(1)–O(3) 109.3(2) 110.8(1)
O(4)–M(1)–N(2) 114.1(2) 114.3(1)
O(4)–M(1)–S(1) 110.4(2) 110.9(1)
O(3)–M(1)–N(2) 78.6(2) 79.2(1)
N(2)–M(1)–N(1) 78.4(2) 78.9(1)
N(1)–M(1)–S(1) 83.2(2) 82.81(9)
O(3)–M(1)–S(1) 89.9(1) 88.64(8)
N(2)–M(1)–S(1) 135.4(2) 134.66(9)
O(3)–M(1)–N(1) 139.1(2) 139.0(1)
M(1)–S(1)–C(1) 100.4(3) 99.7(1)
M(1)–N(1)–C(2) 125.2(5) 125.9(3)
M(1)–N(2)–C(4) 117.6(5) 118.5(3)
M(1)–N(2)–C(5) 116.0(4) 115.7(3)
M(1)–O(3)–C(10) 113.9(4) 113.5(2)
N(2)–C(4)–O(2) 123.1(8) 126.0(4)
N(1)–C(2)–O(1) 123.5(9) 123.6(4)
C(3)–C(4)–O(2) 125.3(8) 122.9(4)
C(1)–C(2)–O(1) 122.4(8) 122.2(4)
Fig. 2 An ORTEP drawing of the asymmetric anionic unit
[ReO(Ph–ON2S)]− of complex 1b with its numbering scheme. Thermal
ellipsoids are drawn at the 50% probability level.
Fig. 3 Perspective view and atom-labelling scheme of the asymmetric
anionic unit [99gTcO(Ph–ON2S)]− of complex 1c. All non hydrogen atoms
are represented by their 50% thermal probability ellipsoids.
0.70 A˚, respectively. The angles between the opposite atoms of
the equatorial plane deviate from the ideal value of 180◦, N(2)–
M–S(1) and N(1)–M–O(3) being 135.4(2) and 139.1(2)◦ for 1b
and 134.66(9) and 139.0(1)◦ for 1c. In addition, the trigonality
index s, defined by Addison et al.,25 was 0.07 and 0.06 for 1b and
1c, respectively. The M–N(1) and M–N(2) bond distances, ca.
1.98 A˚, are shorter than typical M–N single bonds, ca. 2.15 A˚,26
suggesting multiple bonding character. These bonds lengths are
within the range observed for M–Namide bonds in MVO five-
coordinate square-pyramidal complexes,10,21,22 as well as M–
Sthiolate bond distances (both 2.276 A˚).27 For each complex, two
of the three five-membered rings in the coordination sphere, i.e.
those definedbyMO(3)C(10)C(5)N(2) andMN(2)C(4)C(3)N(1)
adopt the stable envelope conformation. The metal is 0.34 and
0.53 A˚ for 1b and 0.39 A˚ and 0.53 A˚ for 1c out of the mean
plane of the remaining four atoms. On the contrary, the third
five-membered ring defined by N(1)C(2)C(1)S(1)M tends to the
envelope conformation, due to the sulfur atomhaving the largest
displacement of 0.49 A˚ (1b) and 0.44 A˚ (1c) out of the best
mean plane. Moreover, the Ophenolate–M–Namide and Namide–M–
Namide bond angles are all approximately 79◦ which is comparable
with those found in analogous complexes. Then, theM=Obond
distances (1.675(4) in 1b and 1.653(2) A˚ in 1c) are similar with
those found for square-pyramidal MVO complexes such as the
MAG3 derivatives (dTc=O = 1.653(2)◦)27a and analogous semi-
rigid complexes recently developed by Papadopoulos et al.22
(dRe=O = 1.673(5) A˚, dTc=O = 1.657(3) A˚).
HPLC profiles of Re-, 99gTc- and 99mTc-complexes (Fig. 4),
obtained by using a combination of UV-vis and radiometric
detections, revealed that these three species possessed similar
retention times (Table 4), thereby indicating identity of their
molecular structures.7,28
The minor difference of retention times observed between Tc
and Re complexes could be explained by the different polarities
of the [Tc=O]3+ and [Re=O]3+ group.29 These results indicate
Table 4 HPLC retention times of the 99mTc, 99gTc and 185/187Re
complexes
Metallic complexes
Ligand 99mTcO 99gTcO ReO
Ph–ON2S(Trt)a 4.31 (1d) 4.21 (1c) 3.89 (1b)
Ph–S(Trt)N2S(Trt)b 2.74 (2d) 2.64 (2c) 2.51 (2b)
Ph–N3S(Trt)a 3.59 (3d) 3.50 (3c) 3.87 (3b)
Ph–N(SMe)N2S(Trt)b 2.98 (4d) — 2.87 (4b)
a Eluent: MeOH–H2O–TFA (55 : 45 : 0.1). b Eluent: MeOH–H2O–TFA
(70 : 30 : 0.1).
Fig. 4 Comparative reverse-phaseHPLC chromatograms: 2b (rhenium
complex, UV recording at 270 nm, tr = 2.51 min), 2c (99gTc complex,
UV recording at 270 nm, tr = 2.64 min), 2d (99mTc complex, radiometric
detection, tr = 2.74 min).
that our semi-rigid ligands form similar 1 : 1 complexes at
macroscopic (Re/99gTc) and at tracer level (99mTc).
To conclude, in this paper we have shown that semi-rigid Ph–
XN2S-type ligands allow stabilization of identical mono-oxo
Re and Tc species both in the solid and in the solution states.
The incorporation of an aromatic ring fused into the chelate
backbone imparts rigidity to a portion of the ligand enhancing
the formation and stability of the resulting complex by an
entropy effect. The high in vivo stability of the corresponding
99mTc complexes established before7 with the structural details
and correlations reported here provide support for the potential
development of agents as diagnostic (99mTc)/therapeutic (188Re)
matched pairs. Incorporation of biologically active fragments
into this kind of chelate for the development of in vivo target-
specific radiopharmaceuticals remains our main objective.
Experimental
Safety note
CAUTION!: 99gTc is a weak b-emitter (Eb− = 0.292 MeV,
t1/2 = 2.12 × 105 years). All manipulations were carried
out in laboratories approved for low-level radioactivity using
monitored hoods and glove-boxes. When handled in milligram
amounts, 99Tc does not present a serious health hazard because
common laboratory glassware provides adequate shielding.
Bremsstrahlung is not a significant problemdue to the low energy
of the b-particles. However, normal radiation safety procedures
must be used at all times, especiallywith solid samples, to prevent
contamination and inhalation.
General
All chemicals were of the highest purity commercially
available. Solvents were purified by standard methods before
use and stored over 0.3 nm molecular sieves. Technetium
as [NH4][99gTcO4] was obtained from Oak Ridge National
Laboratory. Samples were dissolved in water and treated with
an excess of aqueous ammonia and H2O2 (30%) at 80 ◦C prior
to use to oxidise residual TcO2. Slow evaporation of the solvent
with heating at 40 ◦C afforded [NH4][99gTcO4] as a white powder
which was converted to the [NBu4][TcOCl4] precursor following
a literature method.20 Rhenium(VII) oxide was purchased from
AldrichChem.Co. Itwas converted toReOCl3(PPh3)2 according
to published protocols.9 The ligands N-(2-hydroxyphenyl)-2-
[(triphenylmethylthio)methylcarbonylamino]ethanamide, Ph–
ON2S(Trt); N-[2-triphenylmethylthio)phenyl]-2-[(triphenyl-
methylthio)methylcarbonylamino]ethanamide, Ph–S(Trt)N2S-
(Trt);N-(2-aminophenyl)-2-[triphenylmethylthio)methylcarbonyl-
amino]ethanamide, Ph–N3S(Trt); N-[2-(N-methylamino)phenyl]-
2-[triphenylmethylthio)-methylcarbonylamino]ethanamide, Ph–
N(Me)N2S(Trt) and the corresponding 99mTc complexes have
been prepared as described previously.7
Instrumentation
For rhenium compounds, NMR spectra were recorded on a
Bruker AC 200 (50.323 MHz for 13C and 200.133 MHz for 1H)
or 250 apparatus (62.896MHz for 13C and 250.133MHz for 1H).
Chemical shifts are indicated in d values (ppm) downfield from
internal TMS. 1H NMR and 13C NMR spectra of each complex
were recorded at room temperature in CDCl3 except for 1a, 2a
which were performed in MeOD. Unambiguous assignments,
were established by two-dimensional [1H, 1H] COSY and [1H,
13C] HMQC and HMBC experiments (Table 1).
IR spectra were recorded as KBr pellets on a Bruker Vector
22 spectrophotometer in the range 4000–400 cm−1. Negative
electrospray mass spectra were obtained on a NERMAG R
10–10 mass spectrometer. Microanalysis was performed by the
microanalytical department of the Ecole Nationale Supe´rieure
de Chimie de Toulouse. TLC was performed using precoated
Kieselgel 60 plates F254 (TLC plates, Merck) and was visualised
byUV.Column chromatographywas carried out using “gravity”
silica (SDS silica gel).
For technetium compounds,NMRspectrawere collected on a
Bruker AC-300 apparatus (75.467MHz for 13C and 300.13MHz
for 1H) using SiMe4 as internal reference (1H). FT IR spectra
were recorded on aNicolet 510PFourier transform spectrometer
in the range 4000–400 cm−1 in KBr pellets using a Spectra-Tech
diffuse-reflectance collector accessory. Mass spectra of selected
technetium compounds (ca. 10−6 M solutions) were recorded on
a LCQ instrument (Finnigan, Palo Alto, CA). The complexes
have been directly injected by a syringe pump at a flow of
5 lL min−1. Thin-layer chromatography (TLC) was performed
using sheets from Riedel de Haen (Silica gel 60 F254).
HPLC comparison was achieved on a waters 600E gradient
chromatography with a Waters Lambda Max UV detector, a
SAIP radioactivity detector and an ICS dual integrator for
effluent monitoring and a Satisfaction RP18AB column using
MeOH–H2O–TFA(55 : 45 : 0.1 or 70 : 30 : 0.1) as eluent (flow rate
of 1 mL min−1). The eluate was monitored by UV absorbance at
270 nm for Re and 99gTc complexes, or c-ray detection for 99mTc
complexes.
X-Ray crystal structure determination for compounds 1b and 1c
Diffraction measurements for 1b were performed on a Nonius
Kappa CCD diffractometer using graphite-monochromated
Mo-Ka radiation (k = 0.71073 A˚) while, for 1c, diffraction
data were collected on aNicolet R3m/Vdiffractometer (Mo-Ka
radiation; k = 0.71073 A˚). The structures were solved by direct
methods for 1b and by heavy-atom methods for 1c. Both were
refined with full-matrix least-squares procedure based on F 2.
Structure determination and refinement were performed using
the SIR97,30 Maxus31 andSHELX-9732 programs. 7350 and 3700
independent reflections with I ≥ 2r(I) were used for refinement
of the unit cell for 1b and 1c, respectively. Hydrogens for the
disordered chain of the tBu molecule in compound 1c were not
located. Themost significant details of the crystallography study
are reported in Table 2. A collection of selected bond distance
and angles are shown in Table 3.
CCDC reference numbers 275918 and 275919.
See http://dx.doi.org/10.1039/b508661b for crystallographic
data in CIF or other electronic format.
Synthesis of complexes
[Na][ReO(Ph–ON2S)] 1a and [Na][ReO(Ph–SN2S)] 2a. The
synthesis and characterisation of the two complexes 1a and 2a
have been reported previously.7
[PPh4][ReO(Ph–ON2S)] 1b. 1a (100.0 mg, 0.22 mmol) and
tetraphenylphosphonium chloride (89.2 mg, 0.24 mmol) were
dissolved in a mixture of MeOH (15 mL) and CH2Cl2 (15 mL).
The solution was stirred for 30 min at room temperature and
then allowed to precipitate during 2 days. A red solid was filtered
and washed with cold water and dried under vacuum (126.3 mg,
yield = 75%).
Found: C, 52.23; H, 3.63; N, 3.46. C34H28N2O4PReS requires
C, 52.50; H, 3.63; N, 3.60%; IR: mmax/cm−1 1667, 1638 (CO);
969 (ReO); 1H NMR (250 MHz, CDCl3): dH 3.71 (d, 2JHH =
16.8 Hz, 1 H, CH2S), 4.01 (d, 2JHH = 16.8 Hz, 1 H, CH2S), 4.44
(d, 2JHH = 18.3 Hz, 1 H, CH2N), 5.37 (d, 2JHH = 18.3 Hz, 1 H,
CH2N), 6.63 (dt, 3JHH = 7.6 Hz, 4JHH = 1.2 Hz, 1 H, CHAr), 6.75
(dt, 3JHH = 7.6 Hz, 4JHH = 1.5 Hz, 1 H, CHAr), 6.99 (dd, 3JHH =
7.6 Hz, 4JHH = 1.2 Hz, 1 H, CHAr), 7.52 (m, 8 H, CHAr PPh4 ), 7.69
(m, 8 H, CHAr PPh4 ), 7.83 (m, 4 H, CHAr PPh4 ), 8.22 (dd,
3JHH =
7.6 Hz, 4JHH = 1.5 Hz, 1 H, CHAr); 13C{1H} NMR (62.5 MHz,
CDCl3): dC 40.9 (CH2S), 61.8 (CH2N), 116.1, 118.7, 119.5, 123.4
(4 CHAr), 117.3 (4 CAr PPh4 ), 131.2, 131.4, 134.9, 135.0, 136.3,
136.4 (20 CHAr PPh4 ), 141.4, 171.1 (2 CAr), 187.5, 193.9 (2 CO);
MS (ES−): m/z (%) 437 (60), 439 (100) [M−].
[NBu4][ReO(Ph–ON2S)] 1e. To a boiling solution of Ph–
ON2S(Trt) (148.8 mg, 0.30 mmol) in 40 mL of MeOH was
added a solution of tin(II) chloride (143.5 mg, 0.63 mmol,
in 1 mL of 0.1 M HCl), followed immediately by a solution
of tetrabutylammonium perrhenate (310.6 mg, 0.63 mmol, in
1 mL of MeOH). Refluxing was continued for 5 h, the solution
cooled at room temperature and washed with 20 mL of hexane.
MeOHwas removed and the crude solidwas dissolved inCH2Cl2
(20 mL), then washed with water (20 mL). The organic layer was
dried with solid Na2SO4, filtered and concentrated to dryness.
The crude material was purified by column chromatography
on silica gel (eluent CH2Cl2–MeOH (95 : 5)) followed by two
crystallisations in methanol–ether mixture (3 : 1 v/v). Under
these conditions, [Bu4N]Cl remained in solution and the complex
was obtained as a red–orange powder (105 mg, 52%).
Found: C, 45.75; H, 6.60; N, 5.72. C27H48N3O4ReS requires C,
46.53; H, 6.94; N, 6.03%; IR: mmax/cm−1 1641 (CO), 968 (ReO);
1H NMR (250 MHz, CDCl3): dH 0.99 (m, 12 H, CH3), 1.49 (m,
16 H, CH2), 3.07 (m, 8 H, CH2), 3.79 (d, 2JHH = 17.1 Hz, 1 H,
CH2S), 4.13 (d, 2JHH = 17.1 Hz, 1 H, CH2S), 4.57 (d, 2JHH =
18.4 Hz, 1 H, CH2N), 5.53 (d, 2JHH = 18.4 Hz, 1 H, CH2N), 6.75
(dt, 3JHH = 7.8 Hz, 4JHH = 1.2 Hz, 1 H, CHAr), 6.86 (dt, 3JHH =
7.8 Hz, 4JHH = 1.5 Hz, 1 H, CHAr), 7.05 (dd, 3JHH = 7.8 Hz,
4JHH = 1.2 Hz, 1 H, CHAr), 8.33 (dd, 3JHH = 7.8 Hz, 4JHH =
1.5 Hz, 1 H, CHAr); 13C{1H} NMR (75.5 MHz, CDCl3): dC 13.6
(4 CH3), 19.7, 23.8 (8 CH2), 40.0 (CH2S), 58.6 (4 CH2), 61.2
(1 CH2N), 115.5, 118.3, 119.3, 123.0 (4 CHAr), 140.9, 170.5 (2
CAr), 186.9, 193.1 (2 CO); m/z (%) 437 (60), 439 (100) [M−].
[PPh4][ReO(Ph–SN2S)] 2b. 2a (105.0 mg, 0.22 mmol) and
tetraphenylphosphonium chloride (89.2 mg, 0.24 mmol) were
dissolved in a mixture of MeOH (15 mL) and CH2Cl2 (15 mL).
After 30 min under stirring, the solvent was removed and the
crude was purified by column chromatography on silica gel
(eluent: CH2Cl2–MeOH (95 : 5 then 90 : 10)) to yield the complex
2b as an orange powder (121.0 mg, yield = 73%).
Found: C, 50.86; H, 3.48; N, 3.17. C34H28N2O3PReS2 requires
C, 51.44; H, 3.55; N, 3.53; IR: mmax/cm−1 1665, 1625 (CO); 962
(ReO); 1HNMR (250MHz, CDCl3): dH 3.72 (d, 2JHH = 17.1 Hz,
1 H, CH2S), 3.87 (d, 2JHH = 17.1 Hz, 1 H, CH2S), 4.56 (d, 2JHH =
18.9 Hz, 1 H, CH2N), 4.88 (d, 2JHH = 18.9 Hz, 1 H, CH2N), 6.85
(m, 2H, CHAr), 7.49 (m, 9H, 1CHAr + 8CHAr PPh4 ), 7.65 (m, 8H,
CHAr PPh4 ), 7.80 (m, 4H, CHAr PPh4 ), 8.75 (m, 1H, CHAr);
13C{1H}
NMR (75.5 MHz, CDCl3): dC 39.3 (CH2S), 60.3 (CH2N), 116.8,
118.0 (4 CArPPh4 ), 120.6, 122.9, 124.1, 128.1 (4 CHAr), 130.6,
130.7, 134.3, 134.4, 135.7, 135.8 (20 CHAr PPh4 ), 147.3, 152.2
(2 CAr), 188.7, 192.2 (2 CO); MS (ES−): m/z (%) 453 (60), 455
(100) [M−].
[Et3NH][ReO(Ph–N3S)] 3a. To a stirred suspension of Ph–
N3S(Trt) (144.3 mg, 0.30 mmol) and ReOCl3(PPh3)2 (324.5 mg,
0.39 mmol) in MeOH (40 mL) neat Et3N (148.1 lL, 1.20 mmol)
was added. The mixture was refluxed for 4 h and then cooled to
room temperature. The solvent was removed and the crude pu-
rified by column chromatography on silica gel (eluent: CHCl3–
MeOH (95 : 5 then 90 : 10)) to afford the complex 3a as a
red–orange powder (114.2 mg, yield = 89%).
Found: C, 35.16; H, 4.52; N, 10.68. C16H25N4O3ReS requires
C, 35.61;H, 4.67;N, 10.38%; IR: mmax/cm−1 1635, 1613 (CO); 956
(ReO); 1H NMR (250 MHz, CDCl3): dH 1.23 (t, 3JHH = 7.4 Hz,
9 H, CH3), 3.09 (q, 3JHH = 7.4 Hz, 6 H, NCH2), 3.81 (d, 2JHH =
17.2 Hz, 1 H, CH2S), 4.02 (d, 2JHH = 17.2 Hz, 1 H, CH2S), 4.55
(d, 2JHH = 18.7 Hz, 1 H, CH2N), 5.12 (d, 2JHH = 18.7 Hz, 1 H,
CH2N), 6.62 (m, 1 H, CHAr), 6.88 (m, 2 H, CHAr), 8.21 (m, 1 H,
CHAr); 13C{1H} NMR (75.5 MHz, CDCl3): dC 7.8 (3 CH3), 40.4
(CH2S), 46.5 (3 CH2), 60.0 (1 CH2N), 114.2, 117.5, 117.8, 123.1
(4 CHAr), 140.9, 158.9 (2 CAr), 188.1, 194.0 (2 CO); MS (ES−):
m/z (%) 436 (60), 438 (100) [M−].
[PPh4][ReO(Ph–N3S)] 3b. To a stirred solution of 3a
(118.8 mg, 0.22 mmol) in 10 mL of MeOH and 10 mL of
CH2Cl2 was added tetraphenylphosphonium chloride (71.2 mg,
0.19 mmol). The mixture was stirred for 15 min and then treated
withH2O (20mL).The solutionwas extracted twicewithCH2Cl2
(20 mL). The organic layers were dried withMgSO4, filtered and
dried under vacuum to give a red powder (170.9 mg, yield =
99%).
Found: C, 52.14; H, 3.66; N, 4.89. C34H29N3O3PReS requires
C, 52.57; H, 3.76; N, 5.41%; IR: mmax/cm−1 1648, 1618 (CO); 948
(ReO);1H NMR (250 MHz, CDCl3): dH 3.77 (d, 2JHH = 16.8 Hz,
1 H, CH2S), 3.93 (d, 2JHH = 16.8 Hz, 1 H, CH2S), 4.43 (d, 2JHH =
18.3 Hz, 1 H, CH2N), 5.04 (d, 2JHH = 18.3 Hz, 1 H, CH2N), 6.50
(m, 1 H, CHAr), 6.71 (m, 2 H, CHAr), 7.57 (m, 8 H, CHAr PPh4 ),
7.71 (m, 8 H, CHAr PPh4 ), 7.83 (m, 4 H, CHAr PPh4 ), 8.22 (m, 1 H,
CHAr), 8.79 (s, 1 H, NH);13C{1H}NMR (75.5 MHz, CDCl3): dC
40.2 (CH2S), 60.4 (CH2N), 116.9, 118.0 (4 CArPPh4 ), 114.2, 117.6,
118.2, 122.4 (4 CHAr), 130.6, 130.8, 134.3, 134.4, 135.7, 135.8 (20
CHAr PPh4 ), 140.1, 158.3 (2 CAr), 187.7, 192.8 (2 CO); MS (ES
−):
m/z (%) 436 (60), 438 (100) [M−].
[Et3NH][ReO(Ph–N(Me)N2S)] 4a. Using the same proce-
dure adopted for 3a, Ph–N(Me)N2S(Trt) (148.5 mg, 0.30 mmol)
gave the complex as a red solid (157.5 mg, yield = 95%) which
was contaminated by traces of residual Et3NHCl salt.
IR: mmax/cm−1 1647, 1622 (CO); 953 (ReO); 1H NMR
(250MHz, CDCl3): dH 1.25 (t, 9 H, 3JHH = 7.3 Hz, CH3), 3.01 (q,
3JHH = 7.3 Hz, 6 H, CH2), 3.83 (d, 2JHH = 17.1 Hz, 1 H, CH2S),
3.99 (d, 2JHH = 17.1 Hz, 1 H, CH2S), 4.14 (s, 3 H, CH3), 4.49
(d, 2JHH = 18.6 Hz, 1 H, CH2N), 5.04 (d, 2JHH = 18.6 Hz, 1 H,
CH2N), 6.66 (m, 1 H, CHAr), 6.87 (m, 2 H, CHAr), 8.28 (m, 1 H,
CHAr); 13C{1H} NMR (75.5 MHz, CDCl3): dC 9.1 (3 CH3), 40.8
(1 CH2S), 47.3 (3 CH2), 49.9 (CH3), 60.3 (CH2N), 110.9, 117.7,
118.2, 123.3 (4 CHAr), 142.9, 160.0 (2 CAr), 187.6, 193.4 (2 CO);
MS (ES−): m/z (%) 450 (60), 452 (100) [M−].
[PPh4][ReO(Ph–N(Me)N2S)] 4b. This complex was pre-
pared analogously to 2b in 60% yield using CH2Cl2–MeOH (98
: 2) as eluent for column chromatography purification.
Found: C, 52.27; H, 3.89; N, 4.93. C35H31N3O3PReS requires
C, 53.15; H, 3.95; N, 5.31%; IR: mmax/cm−1 1649, 1625 (CO); 954
(ReO); 1H NMR (250 MHz, CDCl3): 3.79 (d, 2JHH = 17.1 Hz,
1 H, CH2S), 3.97 (d, 2JHH = 17.1 Hz, 1 H, CH2S), 4.14 (s, 3 H,
NCH3), 4.39 (d, 2JHH = 18.6 Hz, 1 H, CH2N), 5.01 (d, 2JHH =
18.6 Hz, 1 H, CH2N), 6.53 (m, 1 H, CHAr), 6.80 (m, 2 H, CHAr),
7.53 (m, 8 H, CHAr PPh4 ), 7.67 (m, 8 H, CHAr PPh4 ), 7.82 (m, 4
H, CHAr PPh4 ), 8.28 (m, 1 H, CHAr);
13C{1H} NMR (75.5 MHz,
CDCl3): 40.2 (CH2S), 49.8 (CH3), 60.3 (CH2N), 110.4 (CHAr),
116.8, 118.0 (4CArPPh4 ), 110.4, 117.4, 117.7, 122.4 (4CHAr), 130.6,
130.8, 134.2, 134.4, 135.8, 135.9 (20 CHAr PPh4 ), 143.4, 160.2 (2
CAr), 187.8, 193.2 (2 CO);MS (ES−):m/z (%) 450 (60), 452 (100)
[M−].
[NBu4][TcO(Ph–ON2S)] 1c. To a stirred green solution of
[NBu4][TcOCl4] (31 mg, 0.062 mmol) in MeOH (3 mL) Ph–
ON2S(Trt) (30 mg, 0.062 mmol) was added. The solution turned
orange suddenly. After 1 h stirring at room temperature, the
solvent was removed by a gentle stream of N2 and the crude
was purified by column chromatography on silica gel (eluent:
CH2Cl2–MeOH (95 : 5)) to afford a yellow powder (29.4 mg,
80%).
IR: mmax/cm−1 1654, 1634 (CO); 953 (TcO); 1H NMR
(300 MHz, CDCl3): dH 0.98 (m, 12 H, CH3), 1.36 (m, 16 H,
CH2), 2.95 (m, 8 H, CH2), 3.85 (d, 2JHH = 16.9 Hz, 1 H, CH2S),
4.04 (d, 2JHH = 16.9 Hz, 1 H, CH2S), 4.61 (d, 2JHH = 18.3 Hz,
1 H, CH2N), 5.19 (d, 2JHH = 18.3 Hz, 1 H, CH2N), 6.75 (dt,
3JHH = 7.8 Hz, 4JHH = 1.1 Hz, 1 H, CHAr), 6.89 (dt, 3JHH =
7.8 Hz, 4JHH = 1.4 Hz, 1 H, CHAr), 7.23 (dd, 3JHH = 7.8 Hz,
4JHH = 1.1 Hz, 1 H, CHAr), 8.24 (dd, 3JHH = 7.8 Hz, 4JHH =
1.4 Hz 1H, CHAr); 13C{1H} NMR (75.5 MHz, CDCl3): dC 13.6
(4 CH3), 19.6 (4 CH2), 23.8 (4 CH2), 36.9 (CH2S), 58.6 (4 CH2),
59.9 (CH2N), 114.7, 118.3, 118.6, 122.9 (4 CHAr), 139.5, 165.2
(2 CAr), 182.5, 185.9 (2 CO); MS (ES−) m/z (%) 351 (100) [M−].
[NBu4][TcO(Ph–SN2S)] 2c. As for 1c, 25 mg (0.05 mmol) of
Ph–S(Trt)N2S(Trt) gave the complex as a yellow–brown oil.
IR: mmax/cm−1 1655, 1638 (CO); 945 (TcO); 1H NMR
(300 MHz, CDCl3): dH 0.94 (m, 12 H, CH3), 1.33 (m, 16 H,
CH2), 2.86 (m, 8 H, CH2), 3.85 (d, 2JHH = 16.9 Hz, 1 H, CH2S);
4.10 (d, 2JHH = 16.9 Hz, 1 H, CH2S), 4.72 (d, 2JHH = 18.9 Hz, 1
H, CH2N), 4.82 (d, 2JHH = 18.9 Hz, 1 H, CH2N), 6.96 (t, 3JHH =
7.6 Hz, 1 H, CHAr), 7.06 (t, 3JHH = 7.6 Hz, 1 H, CHAr), 7.48 (d,
3JHH = 7.6 Hz, 1 H, CHAr), 8.75 (d, 3JHH = 7.6 Hz, 1 H, CHAr);
13C{1H} NMR (75.5 MHz, CDCl3): dC 13.6 (4 CH3), 19.6 (4
CH2), 23.7 (4 CH2), 37.3 (CH2S), 58.5 (4 CH2), 59.3 (CH2N),
120.6, 122.8, 124.3, 127.0 (4 CHAr), 140.3, 150.1 (2 CAr), 184.0,
186.4 (2 CO); MS (ES−): m/z (%) 367 (100) [M−].
[NBu4][TcO(Ph–N3S)] 3c. To a stirred green solution of
[NBu4][TcOCl4] (16.0 mg, 0.032 mmol) in MeOH (3 mL) was
added Ph–N3S(Trt) (15.4 mg, 0.032 mmol) and an excess of
triethylamine (22.5 lL, 0.160 mmol). The reaction was stirred
for 30 min and the solution turned dark orange. The crude
solution was then treated twice with hexane (2 × 3 mL) and
then the solvents were removed. The solid was dissolved in
CH2Cl2 (5 mL), treated with water (5 mL), and the organic
layers were separated, dried and concentrated to dryness. The
title compound was obtained as a yellow–orange solid (15 mg,
79%).
1H NMR (300 MHz, CDCl3): dH 0.95 (m, 12 H, CH3), 1.30
(m, 16 H, CH2), 2.84 (m, 8 H, CH2), 3.72 (d, 2JHH = 16.7 Hz,
1 H, CH2S), 4.07 (d, 2JHH = 16.7 Hz, 1 H, CH2S), 4.58 (d,
2JHH = 18.6 Hz, 1 H, CH2N), 4.93 (d, 2JHH = 18.6 Hz, 1 H,
CH2N), 6.65 (t, 3JHH = 7.2 Hz, 1 H, CHAr), 6.80 (m, 2 H, CHAr),
8.03 (s, 1 H, NH), 8.28 (d, 3JHH = 7.2 Hz, 1 H, CHAr); 13C{1H}
NMR (75.5 MHz, CDCl3): dC 13.6 (4 CH3), 19.6 (4 CH2), 23.6
(4 CH2), 37.3 (CH2S), 58.3 (4 CH2), 59.4 (CH2N), 113.6, 117.8,
118.1, 122.8 (4 CHAr), 139.9, 153.8 (2 CAr), 183.3, 186.2 (2 CO);
MS (ES−): m/z (%) 350 (100) [M−].
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